Our result was also consistent with the data of a previous study showing that infiltration of CD8+T cells can be used adjunctively with PD-L1 expression as a predictive marker for nivolumab treatment in ESCC [30]. The gene discussed is CD274; the disease is esophageal squamous cell carcinoma.